Trial intelligence / Profile preview

Effect of Different Remimazolam Induction Methods on Hemodynamics During Gynecological Day Anesthesia

ChiCTR2500098121Phase 4Not yet recruiting

Sponsor
Weifang People's Hospital
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in hypotension (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Incidence of hypotension. Planned start Mar 2025; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

hypotension

Beyond the preview

Go deeper on ChiCTR2500098121.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500098121.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call